October 3, 2022 Columns by Ed Tobias MS News That Caught My Eye Last Week: ODRS Test, Kesimpta, Coping Strategies, Dual Tasking Study Supports MS Disability Test Score as Outcome Measure in Trials Adding two other disability measurements to the commonly used Expanded Disability Status Scale (EDSS) is a good idea, not only for trials but also in everyday patient assessments as well. Measuring our level of disability using only…
May 20, 2022 News by Marta Figueiredo, PhD Progressive MS, Degree of Disability Increase Infection Risk People with progressive forms of multiple sclerosis (MS) and those with greater MS-related disability have a significantly greater risk of serious infections relative to people without the disease, according to a population-based study in Sweden. Notably, these associations were observed regardless of the use of disease-modifying therapies, many…
April 4, 2022 News by Margarida Maia, PhD COVID-19 Not Linked to Long-term Worsening of RRMS: Iranian Study COVID-19 does not seem to be linked to increased disability worsening or more relapses in the long term for people with relapsing-remitting multiple sclerosis (RRMS), an Iranian study suggests. The study was relatively small, the researchers noted, indicating that more research is needed in the future to determine the…
June 10, 2021 News by Steve Bryson, PhD Gilenya’s Optimal Dose for RRMS Confirmed in Review of Clinical Trials Gilenya (fingolimod) at itsĀ approved 0.5 mg daily dose continues to be the optimal dose for peopleĀ with relapsing-remitting MS (RRMS), a systematic review of 11 clinical trials confirmed. A 0.25 mg/day dose, however, also showed improvement over placebo in MRI outcomes and patient satisfaction, the researchers noted, and further…
August 5, 2020 News by Patricia Inacio, PhD Coffee May Help Ease Fatigue in MS Patients With Milder Disability Drinking coffee each day appears to help people withĀ multiple sclerosis (MS) and milder disability and fatigue, with this patient group reporting in a questionnaire that caffeine allowed them to better concentrate on tasks and broaden their attention spans, a study reports. Its researchers suggest that “for selected patients”Ā regular coffee…
September 19, 2016 News by Patricia Inacio, PhD #ECTRIMS2016 – Modeling Approach Able to Identify Likely Disease Trajectory in Progressive MS Patients Long-term observationsĀ together withĀ mathematicalĀ modelingĀ present a wayĀ of predicting the likelyĀ disability trajectory of multiple sclerosis (MS) patients. The approachĀ was outlinedĀ in a presentation, titled āLong-term disability trajectories in primary progressive MS patients – a latent class growth analysis,ā given atĀ theĀ 32nd Congress of theĀ European Committee for Treatment and Research in Multiple SclerosisĀ (ECTRIMS), held in London…
September 12, 2016 News by Joana Fernandes, PhD Can MS Be Detected by Biomarkers in the Blood? Yes, Study Says MicroRNAs present in the blood show promise as potential biomarkers of multiple sclerosis (MS), a new study suggests. The study, titled āComprehensive Evaluation Of Serum MicroRNAs As Biomarkers In Multiple Sclerosis,ā was published by Keren Regev, MD, and colleagues in the journal Neurology. Human DNA contains…
June 29, 2016 News by Patricia Silva, PhD High Blood Pressure in MS Seen to Increase Risk of Disability Progression High blood pressure mayĀ be linkedĀ to greater overall disability in people with multiple sclerosis (MS), although the rate at which disability progresses mightĀ be slower than in patients without hypertension, a retrospective studyĀ concludes. The research, involvingĀ a large number of MS patients, helps to clarify a rather confusing range of views on how…